Duricef Side Effects
Generic name: cefadroxil
Medically reviewed by Drugs.com. Last updated on Aug 6, 2024.
Note: This document provides detailed information about Duricef Side Effects associated with cefadroxil. Some dosage forms listed on this page may not apply specifically to the brand name Duricef.
Applies to cefadroxil: oral capsule, oral powder for suspension, oral tablet.
Serious side effects of Duricef
Along with its needed effects, cefadroxil (the active ingredient contained in Duricef) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking cefadroxil:
Rare side effects
- black, tarry stools
- bleeding gums
- blistering, peeling, or loosening of the skin
- blood in the urine or stools
- chills
- clay-colored stools
- cough or hoarseness
- dark-colored urine
- diarrhea
- difficulty with moving
- feeling of discomfort
- fever
- fever with or without chills
- flushing or redness of the skin
- general feeling of tiredness or weakness
- headache
- inflammation of the joints
- itching
- joint or muscle pain
- light-colored stools
- lower back or side pain
- muscle aches
- muscle pain or stiffness
- painful or difficult urination
- pinpoint red spots on the skin
- rash
- red skin lesions, often with a purple center
- red, irritated eyes
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- stomach pain, continuing
- swollen lymph glands
- unusual bleeding or bruising
- unusually warm skin
- vomiting
- yellow eyes or skin
Incidence not known
- abdominal or stomach cramps or tenderness
- back, leg, or stomach pains
- bloating
- chest pain
- coughing up blood
- diarrhea, watery and severe, which may also be bloody
- difficulty with breathing or swallowing
- dizziness
- fast heartbeat
- general body swelling
- high fever
- hives
- increased menstrual flow or vaginal bleeding
- increased thirst
- itching
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- loss of appetite
- nausea
- nosebleeds
- pain
- pale skin
- paralysis
- prolonged bleeding from cuts
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- seizures
- shortness of breath
- sudden decrease in the amount of urine
- swollen or painful glands
- tightness in the chest
- unpleasant breath odor
- unusual tiredness or weakness
- unusual weight loss
- vomiting of blood
- wheezing
Other side effects of Duricef
Some side effects of cefadroxil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Rare side effects
- acid or sour stomach
- belching
- heartburn
- indigestion
- stomach discomfort, upset, or pain
Incidence not known
- hives or welts
- itching of the vagina or genital area
- itching or pain of the genital area
- pain during sexual intercourse
- redness of the skin
- thick, white vaginal discharge with no odor or with a mild odor
For healthcare professionals
Applies to cefadroxil: oral capsule, oral powder for reconstitution, oral tablet.
Gastrointestinal adverse events
- Common (1% to 10%): Abdominal discomfort, abdominal pain, diarrhea, dyspepsia, glossitis, nausea, vomiting
- Very rare (less than 0.01%): Pseudomembranous colitis
- Frequency not reported: Colitis[Ref]
Mild to life-threatening pseudomembranous colitis has been reported in patients given this drug; this side effect may occur during or after treatment.[Ref]
Dermatologic
- Common (1% to 10%): Allergic exanthema, pruritus, rash, urticaria
- Very rare (less than 0.01%): Erythema multiforme, Stevens-Johnson syndrome
- Frequency not reported: Toxic epidermal necrolysis[Ref]
Immunologic
- Uncommon (0.1% to 1%): Opportunistic organism/fungal growth, thrush
- Rare (0.01% to 0.1%): Serum sickness, serum sickness-like reactions
- Frequency not reported: Superinfection[Ref]
Genitourinary
- Uncommon (0.1% to 1%): Genital candidiasis/genital moniliasis/vaginal mycoses
- Rare (0.01% to 0.1%): Genital pruritus, vaginitis[Ref]
Hematologic
- Rare (0.01% to 0.1%): Agranulocytosis, eosinophilia, leukopenia, moderate transient neutropenia/neutropenia, thrombocytopenia
- Very rare (less than 0.01%): Direct/indirect positive Coombs tests, hemolytic anemia (immunologic origin)
- Frequency not reported: Aplastic anemia, pancytopenia, prolonged prothrombin time[Ref]
Agranulocytosis, eosinophilia, leukopenia, neutropenia, and/or thrombocytopenia occurred during prolonged treatment, but usually subsided upon discontinuation of treatment.[Ref]
Hypersensitivity
- Rare (0.01% to 0.1%): Angioneurotic edema/angioedema
- Very rare (less than 0.01%): Anaphylactic shock, immediate allergic reaction
- Frequency not reported: Allergies, anaphylaxis[Ref]
Allergies included anaphylaxis, angioedema, pruritus, rash, and urticaria. Most allergy symptoms subsided upon treatment discontinuation.[Ref]
Other
- Rare (0.01% to 0.1%): Drug fever/fever
- Very rare (less than 0.01%): Fatigue[Ref]
Hepatic
- Rare (0.01% to 0.1%): Liver dysfunction
- Very rare (less than 0.01%): Cholestasis, idiosyncratic liver failure, minor transaminase elevations (ALT, AST, alkaline phosphatase)
- Frequency not reported: Elevated bilirubin[Ref]
Renal
- Rare (0.01% to 0.1%): Interstitial nephritis
- Frequency not reported: Increased blood urea nitrogen (BUN), increased creatinine, renal dysfunction, toxic nephropathy[Ref]
Musculoskeletal
- Rare (0.01% to 0.1%): Arthralgia[Ref]
Nervous system
- Very rare (less than 0.01%): Dizziness, headache, sleeplessness
- Frequency not reported: Seizures[Ref]
Metabolic
- Frequency not reported: Elevated lactate dehydrogenase (LDH)[Ref]
Cardiovascular
- Frequency not reported: Hemorrhage[Ref]
Psychiatric
- Very rare (less than 0.01%): Nervousness[Ref]
References
1. (2002) "Product Information. Duricef (cefadroxil)." Bristol-Myers Squibb
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
Frequently asked questions
More about Duricef (cefadroxil)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Dosage information
- During pregnancy
- Drug class: first generation cephalosporins
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Duricef side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.